Federal ban on grant-funded drug test strips sparks overdose concerns in Baltimore
A new SAMHSA rule bars federal grant money from buying benzodiazepine test strips for users, raising fears of more overdoses in Baltimore.
Following three severe overdose events in Baltimore's Penn North area, the local Harm Reduction Coalition created low-cost test strips to detect benzodiazepines and other adulterants. The organization distributes the strips at clinics, events, bars and street corners, allowing users to test substances before consumption. In April, SAMHSA issued a directive that federal grant funds may no longer be used for public distribution of these strips or related harm-reduction tools, arguing they conflict with federal law.
The rule still allows agencies such as police and EMTs to acquire strips for testing supplies. Experts like Yngvild Olsen cite evidence that strip availability can change user behavior and reduce overdose risk, while HHS spokesperson Emily Hilliard emphasizes funding should focus on proven interventions like naloxone. Coalition spokesperson Candy Kerr warns the funding loss may force cuts to other services, potentially jeopardizing progress in lowering Baltimore's overdose deaths.
Why it matters
The funding ban could limit a proven tool that helps drug users avoid fatal overdoses.
In this story